Home/Filings/4/0000899243-22-006633
4//SEC Filing

Hwang Sooin 4

Accession 0000899243-22-006633

CIK 0001796129other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:10 PM ET

Size

5.5 KB

Accession

0000899243-22-006633

Insider Transaction Report

Form 4
Period: 2022-02-14
Hwang Sooin
Chief Business Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-14+34,00034,000 total
    Exercise: $6.26Exp: 2032-02-13Common Stock (34,000 underlying)
Footnotes (1)
  • [F1]Option vests over three years, with 1/3 of the shares vesting on December 23, 2022, and 1/36th of the shares vesting monthly thereafter.

Issuer

Vincerx Pharma, Inc.

CIK 0001796129

Entity typeother

Related Parties

1
  • filerCIK 0001862522

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:10 PM ET
Size
5.5 KB